These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26047087)

  • 1. Hepatitis C virus screening to reveal a better picture of infection.
    Medici MC; Galli C; Calderaro A
    Trends Microbiol; 2015 Jun; 23(6):324-6. PubMed ID: 26047087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving hepatitis C screening and access to treatment.
    Alberts R; Zimmermann A; Martinez A
    JAAPA; 2022 Oct; 35(10):17-21. PubMed ID: 36165543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review: economic evaluations of HCV screening in the direct-acting antivirals era.
    Cortesi PA; Barca R; Giudicatti G; Mossini S; Ciaccio A; Iannazzo S; Micale M; Cesana G; Mantovani LG
    Aliment Pharmacol Ther; 2019 May; 49(9):1126-1133. PubMed ID: 30843268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt.
    El-Kamary SS; Hashem M; Saleh DA; Ehab M; Sharaf SA; El-Mougy F; Abdelsalam L; Jhaveri R; Aboulnasr A; El-Ghazaly H
    J Infect; 2015 May; 70(5):512-9. PubMed ID: 25623176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology and clinical aspects on hepatitis C.
    Higuchi M; Tanaka E; Kiyosawa K
    Jpn J Infect Dis; 2002 Jun; 55(3):69-77. PubMed ID: 12195046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatitis C].
    Moradpour D; Blum HE
    Ther Umsch; 2004 Aug; 61(8):493-8. PubMed ID: 15457965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral hepatitis C in 2014--the beginning of the end?
    Prelipcean CC; Gogălniceanu P; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(2):272-8. PubMed ID: 25076687
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of timing and prioritization on the cost-effectiveness of birth cohort testing and treatment for hepatitis C virus in the United States.
    McEwan P; Ward T; Yuan Y; Kim R; L'italien G
    Hepatology; 2013 Jul; 58(1):54-64. PubMed ID: 23389841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of chronic hepatitis C and one-time hepatitis C virus testing of persons born during 1945 to 1965 in the United States.
    Ward JW
    Clin Liver Dis; 2013 Feb; 17(1):1-11. PubMed ID: 23177279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C and drug use: epidemiology, screening, natural history and treatment].
    Lucidarme D
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B112-20. PubMed ID: 12180278
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C.
    Ahmad J
    BMJ; 2017 Jul; 358():j2861. PubMed ID: 28684552
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the hepatitis C virus epidemic over in Egypt? Incidence and risk factors of new hepatitis C virus infections.
    Mostafa A; Taylor SM; el-Daly M; el-Hoseiny M; Bakr I; Arafa N; Thiers V; Rimlinger F; Abdel-Hamid M; Fontanet A; Mohamed MK
    Liver Int; 2010 Apr; 30(4):560-6. PubMed ID: 20141592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying cost-effective screening algorithms for active hepatitis C virus infections in a high prevalence setting.
    Jülicher P; Galli C
    J Med Econ; 2018 Jan; 21(1):1-10. PubMed ID: 28881157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Elimination of hepatitis C virus in Denmark].
    Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
    Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus in Pregnancy: An Opportunity to Test and Treat.
    Fogel RS; Chappell CA
    Obstet Gynecol Clin North Am; 2023 Jun; 50(2):363-373. PubMed ID: 37149316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
    AASLD/IDSA HCV Guidance Panel
    Hepatology; 2015 Sep; 62(3):932-54. PubMed ID: 26111063
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis C virus (HCV): a silent epidemic.
    Bandy U
    Med Health R I; 1999 Jun; 82(6):223-4. PubMed ID: 10402843
    [No Abstract]   [Full Text] [Related]  

  • 20. Elimination of HCV in Russia: Barriers and Perspective.
    Isakov V; Nikityuk D
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.